Search

25 Jul 2024: internships delivered partly in Cambridge and partly at Unicamp by experts in technology commercialisation, university-business collaboration and entrepreneurship education. ... whole exchange with Cambridge Enterprise professionals has been of great

25 Jul 2024: the University in December 2006.br / Her tenure as Chief Executive was a period of significant achievement for Cambridge Enterprise. ... in December 2006./p pHer tenure as Chief Executive was a period of significant achievement for Cambridge Enterprise.

25 Jul 2024: Franklin of the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute is developing a new regenerative therapy for multiple sclerosis (MS). ... for drug discovery and development are invited to contact Cambridge Enterprise, the

25 Jul 2024: enterprise.cam.ac.uk"Cambridge Enterprise/a./p preA possible new method for treating pancreatic cancer which enables the body’s immune system to attack and kill cancer cells has been ... cite/div /div /blockquote /div pInitial tests of the combined

25 Jul 2024: a variety of fascinating, often exciting consultancy projects./p /div /blockquote /div pHugh relies on Cambridge Enterprise’s Consultancy Services team to handle all the administrative work surrounding these projects. ... noise of the bells!/p pAs Hugh

25 Jul 2024: cam.ac.uk/case-studies/xampla-pioneering-a-plastic-free-future/ Tegen Amos Tue, 06 Feb 2024 17:12:02 0000 Amadeus Capital Partners B Corp status cambridge angels CIECH Ventures ... care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin

25 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... a appeared first on a

25 Jul 2024: by University of Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe U.S. ... the animal antibody with human equivalents – for the drug to be successful in humans.

25 Jul 2024: rel="noopener noreferrer"Cycle Pharmaceuticals/a, a Cambridge-based company, the researchers identified six known molecules that they thought might inhibit the PARP enzymes. ... were going to cure hardening of the arteries.”/p pThe technology has been

25 Jul 2024: Andrew Walsh/cite/div /div /blockquote /div p“XO1 has made great progress with Ichorcumab,” said Dr Andrew Walsh, a technology manager at Cambridge Enterprise. ... Enterprise/a./p preThe University laboratories at the Stevenage Bioscience Catalyst,